Apple Inc. v. Alivecor, Inc. ( 2023 )

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 APPLE INC., Case No. 22-cv-07608-HSG 8 Plaintiff, ORDER GRANTING MOTION TO STAY 9 v. Re: Dkt. No. 62 10 ALIVECOR, INC., 11 Defendant. 12 13 On October 23, 2023, Defendant AliveCor, Inc. (“Defendant” or “AliveCor”) filed a 14 motion to stay the case pending completion of inter partes review (“IPR”) proceedings. Dkt. No. 15 62 (“Mot.”). The Court, in its discretion, finds this matter suitable for resolution without oral 16 argument. See Civ. L.R. 7–1(b). For the reasons articulated below, the Court GRANTS 17 AliveCor’s motion and stays this action pending the institution decisions regarding its IPR 18 petitions. 19 I. BACKGROUND 20 Plaintiff Apple, Inc. (“Apple”) filed this action for patent infringement on December 12, 21 2022. Dkt. No. 1. In the Complaint, Apple alleges direct and indirect infringement of four 22 patents, all related to electrocardiogram (“EKG”) technology and related applications: U.S. Patent 23 Nos. 10,076,257 (“the ’257 Patent”); 10,270,898 (“the ‘898 Patent”); 10,866,619 (“the ’619 24 Patent”); 10,568,533 (“the ’533 Patent”) (collectively “Asserted Patents”). See id. ¶¶ 13, 16, 19, 25 22. Apple asserts at least claim 1 of the ’257 Patent (id. ¶ 30); at least claim 1 of the ’619 Patent 26 (id. ¶ 57); at least claim 1 of the ’898 Patent (id. ¶ 86); and at least claim 20 of the ’533 Patent (id. 27 ¶ 119). The accused products are AliveCor’s KardiaMobile Card, KardiaMobile, KardiaMobile 1 (collectively, “Accused Products”). Id., ¶ 24. 2 On June 7, 2023, AliveCor filed two petitions for inter partes review (“IPR”) at the United 3 States Patent and Trademark Office (“USPTO”), challenging the patentability of the ’619 Patent 4 (IPR2023-00948 and IPR2023-00949) and one petition for IPR challenging the patentability of the 5 ’257 Patent (IPR2023-00950). Mot. at 2. On September 27, 2023, and October 30, 2023, 6 AliveCor filed further petitions for IPR challenging the patentability of the ’898 Patent and ’533 7 Patent, respectively (IPR2023-01434 and IPR2024-00095). Id. On October 23, 2023, AliveCor 8 filed this motion, requesting that the Court stay this action pending resolution of the IPRs. The 9 USPTO is expected to issue decisions whether to institute IPR2023-00948 and IPR2023-00949 on 10 January 12, 2024, and whether to institute IPR 2023-00950 on January 11, 2024. Id. The 11 institution decision for IPR2023-01434 is expected on April 5, 2024, and IPR2024-00095 is 12 expected shortly thereafter. Finally, the USPTO has instituted an IPR proceeding as to the ’257 13 Patent, brought by Masimo Corporation, on October 16, 2023. Id. 14 II. LEGAL STANDARD 15 “Courts have inherent power to manage their dockets and stay proceedings, including the 16 authority to order a stay pending [IPR].” Ethicon, Inc. v. Quiggin, 849 F.2d 1422, 1426–27 (Fed. 17 Cir. 1988) (internal citations omitted); IXI Mobile (R & D) Ltd. v. Samsung Elecs. Co., No. 15-cv- 18 03752-HSG, 2015 WL 7015415, at *2 (N.D. Cal. Nov. 12, 2015). Courts consider three factors in 19 determining whether to grant a stay pending IPR: “(1) whether discovery is complete and whether 20 a trial date has been set; (2) whether a stay will simplify the issues in question and trial of the case; 21 and (3) whether a stay would unduly prejudice or present a clear tactical disadvantage to the non- 22 moving party.” IXI Mobile (R & D) Ltd., 2015 WL 7015415, at *2 (quoting Evolutionary 23 Intelligence, LLC v. Facebook, Inc., No. 13-cv-04202-SI, 2014 WL 261837, at *1 (N.D. Cal. Jan. 24 23, 2014)). The moving party bears the burden of demonstrating that a stay is appropriate. DSS 25 Tech. Mgmt., Inc. v. Apple, Inc., No. 14-cv-05330-HSG, 2015 WL 1967878, at *2 (N.D. Cal. May 26 1, 2015). 27 Courts in this district have often recognized “a liberal policy in favor of granting motions 1 WL 4802958, at *2 (N.D. Cal. Oct. 11, 2011); IXI Mobile (R & D) Ltd., 2015 WL 7015415, at *2. 2 Courts, however, must evaluate stay requests on a case-by-case basis. See GoPro, Inc. v. C&A 3 Marketing, Inc., No. 16-cv-03590-JST, 2017 WL 2591268, at *2 (N.D. Cal. June 15, 2017). 4 Ultimately, whether to issue a stay is a matter of the Court’s discretion. 5 III. DISCUSSION 6 A. Factor 1: Stage of Proceedings 7 “The first factor the Court considers is whether the litigation is at an early stage.” Cooler 8 Master Co. v. Asetek Danmark A/S, No. 21-CV-04627-HSG, 2022 WL 2673089, at *2 (N.D. Cal. 9 June 14, 2022) (citing AT&T Intellectual Property I v. Tivo, Inc., 774 F. Supp. 2d 1049, 1052 10 (N.D. Cal. 2011)). Specifically, courts consider “whether discovery is complete and whether a trial 11 date has been set.” Evolutionary Intelligence, 2014 WL 261837, at *1. 12 AliveCor contends that this factor weighs in favor of a stay because “[t]his case 13 undoubtedly remains in the initial stages of litigation” and “[t]his is not a case where a substantial 14 amount of fact discovery has been completed.” Mot. at 4. AliveCor represents that neither party 15 has taken a single deposition, nor engaged in expert discovery. Id. Apple contends that this factor 16 weighs against a stay as claim construction is underway, and Apple has filed its opening claim 17 construction brief. See Dkt. No. 88. 18 While the Court recognizes that claim construction has begun, the Court finds that this case 19 is still at a relatively early stage overall. Discovery is far from complete, and no trial date has 20 been set. Accordingly, this factor weighs in favor of a stay, certainly at least until the USPTO 21 issues institution decisions as to the AliveCor IPR petitions. 22 B. Factor 2: Simplification of Case 23 AliveCor argues that a stay would simplify the issues in this case, “by rendering some or 24 all of Apple’s infringement claims moot, simplifying AliveCor’s invalidity arguments at trial, and 25 providing the Court with the USPTO’s expert opinion on the claims at issue.” Mot. at 5. 26 Apple does not meaningfully dispute that the IPRs could simplify the issues in this case, 27 instead arguing that it is unlikely the USPTO will institute based on AliveCor’s IPR petitions 1 Apple urges the Court to consider the merits of AliveCor’s IPR petitions and conclude that the 2 USPTO likely will decline institution, such that a stay would unnecessarily delay this case. The 3 Court declines to do so. The institution decisions regarding the AliveCor IPR petitions are 4 expected soon, and a stay until those decisions are issued will not unduly delay the case. There is 5 no reason for the Court to delve into the merits of these IPR petitions when the USPTO’s 6 decisions are imminent. And once Apple’s invitation to prejudge the outcome of those decisions 7 is set to the side, this case squarely presents the usual situation in which the results of any 8 instituted IPRs obviously could simplify the case. Therefore, this factor also weighs in favor of a 9 stay pending the institution decisions. 10 C. Factor 3: Prejudice and Disadvantage 11 The final factor considers whether a stay would unduly prejudice the nonmoving party. In 12 assessing this factor, courts “address four considerations when evaluating prejudice: (1) the timing 13 of the IPR petition; (2) the timing of the stay request; (3) the status of review; and (4) the 14 relationship of the parties.” Cooler Master, 2022 WL 2673089, at *2 (citing SAGE 15 Electrochromics, Inc. v. View, Inc., No. 12-cv-06441-JST, 2015 WL 66415, at *3 (N.D. Cal. Jan. 16 5, 2015)). 17 i. Timing of IPR Petitions and Request to Stay 18 AliveCor filed its earliest IPR petitions on June 7, 2023, and filed this motion on October 19 23, 2023, roughly a week before the filing of its final IPR petition. Stays pending IPR can result 20 in substantial delay in the district court proceeding, but the current record does not support a 21 finding of purposeful delay or lack of diligence by AliveCor. The Court finds that the timing of 22 the IPR petitions and motion to stay weighs in favor of a stay. 23 ii. Status of Proceedings 24 Institution decisions in the AliveCor IPR petitions are expected shortly, with the earliest 25 within a few weeks of the date of this order. Moreover, the USPTO has instituted one IPR 26 proceeding against the ’257 Patent, which AliveCor represents as including “some overlapping 27 prior art asserted in AliveCor’s petition.” Dkt. No. 69 (“Reply”) at 5. Thus, this subfactor also iii. Relationship of the Parties 1 In considering the relationship of the parties, the Court asks if the parties are direct 2 competitors, which would increase the risk of prejudice to the non-moving party. See TPK Touch 3 Sols. Inc. v. Wintek Electro-Optics Corp., No. 13-cv-02218 JST, 2013 WL 6021324, at *5 (N.D. 4 Cal. Nov. 13, 2013). However, courts in this district require “evidence to substantiate an 5 argument that direct competition will result in prejudice to the non-moving party.” Cypress 6 Semiconductor Corp. v. GSI Tech., Inc., No. 13–CV–02013–JST, 2014 WL 5021100, at *5 (N.D. 7 Cal. Oct. 7, 2014) (collecting cases). AliveCor represents that it and Apple were, but no longer 8 are, direct competitors. See Mot. at 7; Reply at 3. For its part, Apple does not contend that the 9 parties are currently direct competitors, but argues that AliveCor’s positions in this motion are 10 inconsistent with positions it has taken in other cases. Opp. at 3. 11 Apple’s primary argument on this factor is that the risk of prejudice is high because the 12 relationship between the parties is “unique,” in that this case is part of a “broader set of legal 13 disputes between the parties.” Opp. at 2. It argues that AliveCor is seeking an “unfair advantage” 14 here by asking to delay this proceeding while simultaneously seeking resolution of other disputes 15 where it is the petitioning party, including in this District and before the United States 16 International Trade Commission. Id. The Court is not convinced that Apple has established 17 “evidence to substantiate its general assertions that a stay will result in competitive injury.” 18 Cooler Master, 2022 WL 2673089, at *3. Apple’s sole argument here is that there are other 19 proceedings in which AliveCor has not sought a stay, but those proceedings involve entirely 20 different patents – or in the case of the antitrust lawsuit, entirely different claims – such that a stay 21 may or may not have been appropriate given the circumstances in those cases. Apple provides no 22 evidence as to why the relationship of the parties, or the existence of those pending parallel 23 actions, would uniquely prejudice Apple beyond the delay necessarily inherent in any stay. See 24 PersonalWeb Techs., LLC v. Apple Inc., 69 F. Supp. 3d 1022, 1029 (N.D. Cal. 2014). Absent such 25 evidence, the Court does not find that a stay at least until institution decisions issue on the 26 AliveCor IPR petitions would uniquely or unduly prejudice Apple here. 27 IV. CONCLUSION Having considered the relevant factors in their entirety, the Court finds in its discretion that 2 a stay of this case pending at least the first institution decisions on AliveCor’s IPR petitions is 3 warranted. Accordingly, the Court GRANTS AliveCor’s motion to stay pending an initial 4 decision by the USPTO concerning whether to institute AliveCor’s IPR petitions. Within seven 5 days of the issuance of the USPTO’s decisions on whether to institute IPR on the ’619 and °257 6 Patents, the parties shall file a joint status report of no more than one page, without any argument, 7 simply notifying the Court of the decisions and attaching copies. Once it reviews that report, the 8 Court will decide whether to lift or continue the stay, which remains in place unless and until 9 otherwise ordered. 10 IT IS SO ORDERED. 1] Dated: December 29, 2023 12 . . jAYWooDSGILAM HAYWOOD S. GILLIAM, JR. 14 United States District Judge 16 Oo Z 18 19 20 21 22 23 24 25 26 27 28